|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"徐志宏"
Showing items 51-75 of 154 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2013 |
Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma.
|
Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 林家齊; 鄭安理; 黃大成; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2013 |
Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC
|
Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 謝明書 |
| 國立臺灣大學 |
2012 |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen, T. -J.; Chung, C. -S.; Wu, Y. -W.; Yen, R. -F.; Cheng, M. -F.; Lee, J. -M.; Hsu, C. -H.; Chang, Y. -L.; Wang, H. -P.; 吳彥雯; 張逸良; 顏若芳; 徐志宏; 李章銘; 王秀伯; 鄭媚方 |
| 國立臺灣大學 |
2012 |
Efficacy, Safety, and Potential Biomarkers of Thalidomide plus Metronomic Chemotherapy for Advanced Hepatocellular Carcinoma
|
Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chiun; Lee, Kuan-Der; Hsiao, Chi-Huang; Lu, Yen-Shen; Huang, Chien-Chung; Shen, Yin-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii; 盧彥伸; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Serum Insulin-Like Growth Factor-1 Levels Predict Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Antiangiogenic Therapy
|
Shao, Yu-Yun; Huang, Chien-Chung; Lin, Shiou-Der; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Metastasectomy of Krukenberg Tumors May Be Associated with Survival Benefits in Patients with Metastatic Gastric Cancer
|
Lu, Li-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Hsu, Chun; Cheng, Wen-Fang; Lin, Yu-Lin; Cheng, Ann-Lii; Yeh, Kun-Huei; 鄭文芳; 邵幼雲; 林育麟; 鄭安理; 徐志宏; 許駿; 葉坤輝; 呂理駿 |
| 國立臺灣大學 |
2012 |
FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR EVALUATING EARLY RESPONSE DURING NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
|
Lin, C. -C.; Hsu, C. -H.; Tzen, K. -Y.; Cheng, J. C.; Lee, J. -M.; Wang, H. -P.; Huang, P. -M.; Hsu, F. -M.; Chen, W. -W.; Huang, T. -C.; Cheng, A. -L.; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
HOSPITAL VOLUMES OF PERCUTANEOUS RADIOFREQUENCY ABLATION ASSOCIATED WITH ITS TREATMENT OUTCOMES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA
|
Shao, Y. -Y.; Lu, L. -C.; Kuo, R. N. C.; Lin, Z. -Z.; Yeh, Y. -C.; Shau, W. -Y.; Hsu, C. -H.; Cheng, A. -L.; Lai, M. -S.; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 呂理駿 |
| 國立臺灣大學 |
2012 |
SYNERGISTIC ANTI-TUMOR EFFECT OF SORAFENIB IN COMBINATION WITH AKT INHIBITORS IN HEPATOCELLULAR CARCINOMA
|
Feng, W. -C.; Hsu, C. -H.; Lin, S. -D.; Lin, H. -H.; Hsu, D. -W.; Huang, C. -C.; Chow, L. -P.; Cheng, A. -L.; 周綠蘋; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
|
Shao, Y-Y; Lu, L-C; Lin, Z-Z; Hsu, C.; Shen, Y-C; Hsu, C-H; Cheng, A-L; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 許駿; 呂理駿 |
| 國立臺灣大學 |
2012 |
THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS
|
Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 林育誼; 鄭安理; 徐志宏; 許駿; 歐大諒 |
| 國立臺灣大學 |
2012 |
Dissimilar Immunohistochemical Expression of ERK and AKT between Paired Biopsy and Hepatectomy Tissues of Hepatocellular Carcinoma
|
Shao, Yu-Yun; Chen, Chi-Long; Ho, Ming-Chih; Huang, Chien-Chung; Tu, Hui-Ching; Hsu, Chih-Hung; Cheng, Ann-Lii; 邵幼雲; 鄭安理; 徐志宏; 何明志 |
| 國立臺灣大學 |
2012 |
Diabetes Mellitus Is Associated with Increased Mortality in Patients Receiving Curative Therapy for Hepatocellular Carcinoma
|
Shau, Wen-Yi; Shao, Yu-Yun; Yeh, Yi-Chun; Lin, Zhong-Zhe; Kuo, Raymond; Hsu, Chih-Hung; Hsu, Chiun; Cheng, Ann-Lii; Lai, Mei-Shu; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2012 |
Brivanib (BRI) versus Sorafenib (SOR) as First-line Therapy in Patients with Unresectable, Advanced Hepatocellular Carcinoma (HCC): Results from the Phase 3 BRISK-FL Study
|
Johnson, Phillip; Qin, Shukui; Park, Joong-Won; Poon, Ronnie T.; Raoul, Jean-Luc; Philip, Philip A.; Hsu, Chih-Hung; Hu, Tsung-Hui; Heo, Jeong; Xu, Jianming; Lu, Ligong; Chao, Yee; Boucher, Eveline; Han, Kwang-Hyub; Paik, Seung Woon; Robles-Avina, Jorge; Kudo, Masatoshi; Liu, David; Ezzeddine, Rana; Walters, Ian; Cheng, Ann-Lii; 鄭安理; 徐志宏 |
| 國立臺灣大學 |
2012 |
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
|
Lin, Chia-Chi; Hsu, Chih-Hung; Tzen, Kai-Yuan; Cheng, Jason C.; Lee, Jang-Ming; Wang, Hsiu-Po; Huang, Pei-Ming; Hsu, Feng-Ming; Chen, Wei-Wu; Huang, Ta-Chen; Cheng, Ann-Lii; 林家齊; 曾凱元; 鄭安理; 成佳憲; 黃大成; 徐志宏; 李章銘; 王秀伯; 黃培銘; 許峰銘 |
| 國立臺灣大學 |
2012 |
LOW FREQUENCIES OF BRAF AND B-CATENIN (CTNNB1) MUTATIONS IN ADVANCED HEPATOCELLULAR CARCINOMA
|
Lu, L. -C.; Shao, Y. -Y.; Hsieh, M. -S.; Huang, C. -C.; Cheng, A. -L.; Hsu, C. -H.; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書 |
| 臺大學術典藏 |
2012 |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen, T. -J.;Chung, C. -S.;Wu, Y. -W.;Yen, R. -F.;Cheng, M. -F.;Lee, J. -M.;Hsu, C. -H.;Chang, Y. -L.;Wang, H. -P.; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; 吳彥雯 ;張逸良 ;顏若芳 ;徐志宏 ;李章銘 ;王秀伯 ;鄭媚方; Yen, T. -J.; Yen, T. -J.; Chung, C. -S.; Chung, C. -S.; Wu, Y. -W.; Yen, R. -F.; Yen, R. -F.; Cheng, M. -F.; Lee, J. -M.; Hsu, C. -H.; Chang, Y. -L.; Wang, H. -P.; 張逸良; 張逸良 |
| 國立臺灣海洋大學 |
2011-06 |
建構綠色供應鏈供應商採購之績效評比模式
|
徐志宏;梁金樹 |
| 國立臺灣海洋大學 |
2011 |
流通服務業發展綠色供應鏈動態績效評價系統之研究－從國際物流觀點
|
Chih-Hung Hsu; 徐志宏 |
| 中國文化大學 |
2010 |
新竹市北門大街再生之研究
|
徐志宏 |
| 國立臺灣大學 |
2010 |
Combinations of Mtorc1 Inhibitor Rad001 with Gemcitabine and Paclitaxel for Treating Non-Hodgkin Lymphoma
|
江俊德; 葉培彥; 高明; 郭頌鑫; 徐志宏; 盧彥伸; 鄭安理; CHIANG, CHUN-TE; YEH, PEI-YEN; GAO, MING; KUO, SUNG-HSIN; HSU, CHIH-HUNG; LU, YEN-SHEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma
|
邵幼雲; 林宗哲; 許駿; 沈盈君; 徐志宏; 鄭安理; SHAO, YU-YUN; LIN, ZONG-ZHE; HSU, CHIUN; SHEN, YING-CHUN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Efficacy and Tolerability of Bevacizumab Plus Capecitabine as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
|
徐志宏; 許駿; 陳培哲; 林宗哲; 趙祖怡; 鄭安理; HSU, CHIH-HUNG; HSU, CHIUN; CHEN, PEI-JER; LIN, ZONG-ZHE; CHAO, TSU-YI; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (Dce-Mri) to Predict Treatment Outcomes for Advanced Hepatocellular Carcinoma (Hcc) Patients Who Received Sorafenib Plus Tegafur/Uracil Therapy
|
沈盈君; 許昭禹; 游治維; 許駿; 徐志宏; 鄭安理; 施庭芳; SHEN, YING-CHUN; HSU, CHAO-YU; YU, CHIH-WEI; HSU, CHIUN; HSU, CHIH-HUNG; CHENG, ANN-LII; SHIH, TIFFANY TING-FANG |
Showing items 51-75 of 154 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
